Contrast Agents Market

Contrast Agents Market is segmented By Category (Iodine based non-ionic contrast media, Magnetic Resonance Imaging contrast agents, Barium sulfate compounds, Contrast-Enhanced Ultrasound), By Way Of Intake (Orally), By enema, By injection, Others, By Application (Radiology, Interventional Cardiology, Interventional Radiology, Others), By End-User (Diagnostic Centres, Hospitals, Others), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) – Share, Size, Outlook, and Opportunity Analysis, 2022-2029

 

 

[150 Pages Report] Global Contract Agents Market is expected to grow at a CAGR of 4-5% during the forecast period (2022-2029).

Contract Agents Market - Strategic Insights

Metrics	Details
Market CAGR	4-5%
Segments Covered	By Category, By Way Of Intake, By Application, By End-User and By Region
Report Insights Covered	Competitive Landscape Analysis, Company Profile Analysis, Market Size, Share, Growth, Demand, Recent Developments, Mergers and acquisitions, New Product Launches, Growth Strategies, Revenue Analysis, and Other key insights.
Fastest Growing Region	Asia Pacific
Largest Market Share	North America

To Get a Free Sample Click here

Growth factors of the global Contrast Agents Market

• Growing demand for minimally invasive treatment methods, the Need for accurate diagnosis in a relatively less period, increase in the prevalence of chronic diseases, etc., is driving the growth of the global Contrast Agents market.

• However, high cost and safety concerns are likely to hinder the growth of the global Contrast Agents market.

Key Highlights of the market

• Diffusion kurtosis imaging, a new MR imaging technique, can perform operations without the use of contrast agents. Increasing such technologies is holding back the growth of the global Contrast Agents Market.

• FDA announced a new class warning and safety measures for all Gadolinium-Based Contrast Agents. Continually changing and the addition of new regulatory guidelines for each segment is likely to affect the overall growth of the Contrast Agents Market.

• TAGITOL V (barium sulfate), a new imaging agent for the use of CT and CTC procedures, is approved by U.S. FDA for use in adult patients. Expanding the scope of contrast agents to additional healthcare verticals is favoring the growth of the global Contrast Agents Market.

Market Segmentation 

• The market is segmented by Category, Way of Intake, Application, and end-users. By Way of intake, the market is segmented as Oral, Enema, Injection, and Others.

• By Application, the market is segmented as Radiology, Interventional Cardiology, Interventional Radiology, and Others.

Geographical Analysis

• The report segments the geographies by region, which include North America, South America, Europe, Asia Pacific, and RoW.

• North America is leading the global Contrast Agents market, with the majority of the contribution from the US. Growing geriatric population, increase in the incidence of chronic diseases, Modernization of healthcare infrastructure, an increasing number of road accidents are fuelling the demand in this region.

• The report profiles the following companies, which include Bayer, BIPSO GmbH, Bracco Imaging, GE Healthcare, Guerbet, Lantheus, Magnus Health, and Spago Nanomedical.

Trending Topics

Radiotherapy Market

Cardiac Restoration Systems Market

Carbon Fiber Market

FAQ

What is the Contract Agents Market growth?

The market is growing at a CAGR of 4-5%

What is Contract Agents Market size in 2021

The Contract Agents Market size was valued at USD YY million in 2021

Who are the key players in Contract Agents Market?

Bayer, BIPSO GmbH, Bracco Imaging, GE Healthcare, Guerbet, Lantheus, Magnus Health